Volume 6 Supplement 1

2nd WAO International Scientific Conference (WISC 2012), Abstracts

Open Access

Asthma diagnosis and treatment – 1016. Is atopy in people aged 40 and over related to fixed airflow obstruction?

  • Michael J Abramson1,
  • Brett G Toelle2,
  • Alan L James3,
  • Richard Wood-Baker4,
  • Deborah Burton5,
  • Wei Xuan2,
  • David P Johns6,
  • A Sonia Buist7 and
  • Guy B Marks2
World Allergy Organization Journal20136(Suppl 1):P16

DOI: 10.1186/1939-4551-6-S1-P16

Published: 23 April 2013


The Tucson and Normative Ageing studies showed atopy was not related to airflow obstruction in later life, when known asthmatics were excluded. However these studies were based on pre-bronchodilator spirometry.


To examine independent associations between atopy and post-bronchodilator airflow obstruction in people aged 40 years and over.


We used data from the BOLD-Australia study. Persons aged 40 years and over were randomly selected from the electoral roll, either directly or via a two stage sampling procedure, in centres based in four Australian States. Spirometry was performed before and after administration of salbutamol 200 μg, according to a standardised protocol with careful attention to quality control. Subjects with post-bronchodilator FEV1/FVC ratio < 0.7 were classified as GOLD stage 1 or higher. Subjects who also had FEV1 < 80% predicted were classified as GOLD stage 2 or higher. Subjects who had a post-bronchodilator increase in FEV1 > 12% of pre-bronchodilator value and > 200 ml were classified as “reversible”. Atopy was assessed by skin prick tests (SPTs) to house dust mites (D. pteronyssinus and D. farinae), cat, dog, cockroach, Alternaria, Aspergillus, rye grass and mixed grass pollens. Subjects with any allergen SPT ≥ 4 mm were classified as atopic.


Post-bronchodilator spirometry and SPT data were available for 2,767 subjects (51.4% female, 12.1% aged ≥ 75). The prevalence of GOLD stage 1 or higher was 15.9%, the prevalence of GOLD stage 2 or higher was 6.8%, and 4.7% had bronchodilator reversibility. One in nine subjects self-reported current asthma and 50.5% had ever been smokers. The prevalence of atopy in this population was 42.7%.

The associations between atopy and airflow obstruction did not differ by self-reported asthma or smoking status (all interactions p > 0.2). However atopy was associated with GOLD stage 2 after adjustment for sex, self-reported current asthma and smoking status (OR=1.56, 95%CI 1.13-2.17). As expected, atopy was related to the presence of bronchodilator reversibility (OR=1.89, 95%CI 1.32-2.72).


The apparent association of atopy with fixed airflow obstruction using post-bronchodilator spirometry in people aged 40 years and over may be due to clinical heterogeneity.

Authors’ Affiliations

Epidemiology & Preventive Medicine, Monash University
Woolcock Institute of Medical Research
Sir Charles Gairdner Hospital
Royal Hobart Hospital
Charles Sturt University
Menzies Research Institute
Oregon Health & Science University


© Abramson et al; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.